Pfizer-BioNTech Report COVID-19 Vaccine is Safe, Effective in Children Aged 5 to 11 Years
Pfizer/BioNTech report "robust" antibody response to COVID-19 vaccine in children aged 5 to 11 years with safety profile comparable to that seen in persons aged 16 to 25 years.
CCTA Imaging Helps ID Silent Atherosclerosis in Adults with No Known CVD
CCTA identified atherosclerosis in >40% of middle-aged adults without known coronary heart disease, report Swedish investigators; significant stenosis was found in another 5.2%.
HFpEF News: Dapagliflozin Improves Symptoms, Exercise Function in PRESERVED-HF
Dapagliflozin adds substantial improvements in symptoms, exercise function to demonstrated disease-modifying properties for patients with HFpEF.
Study: Opioid Overdose Death Rate Climbed Nearly 40% among Black Americans
New research shows opioid overdose death rates increased among Black Americans between 2018 and 2019, despite having leveled off in other ethnic/racial groups.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 17, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Seen in the ED: Hematochezia in a 1-year-old Girl
Intermittent pain causing the child to cry and an episode of bright red rectal bleeding are described by the mother. Review labs and imaging: What's your diagnosis?
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 16, 2021
COVID-19 Hospitalizations for Unvaccinated Cost US Billions
Avoidable COVID-19 hospitalizations for unvaccinated persons in the US have cost an estimated $5 billion since June, according to a new study.
Mental Health in America: Which States are Happiest?
What state has the lowest suicide rate? Which one has the highest share of adult depression? Find the answers and more insights from a nationwide analysis, here.
Common Elective Orthopedic Procedures: Does Research Support Their Use?
What does the evidence show for the clinical effectiveness of 10 of the most common elective orthopedic procedures? A recent umbrella review sheds light.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 15, 2021
White Coat Hypertension & Masked Hypertension: A Primary Care Primer
Identifying white coat and masked hypertension is essential for prevention of CV morbidity and mortality. Review the ACC/AHA recommendations on how to detect and manage.
Elevated Urinary Stress Hormones Up Risk for Hypertension, CV Events in Prospective Cohort Study
Each doubling of levels of 4 stress hormones was associated with a 21-31% increase in risk of developing hypertension over a median 6.5-year follow-up.
Social Determinants of Obesity: Treating Urban & Rural Patients
Social determinants of health vary between patients living in different environments, so what are the key factors to consider when creating a treatment plan?
10 States with the Highest COVID-19 Vaccination Rates, 5 with the Lowest
According to the CDC, Vermont right now has the highest and Wyoming the lowest percentage of its state's population fully vaccinated against COVID-19.
FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine Treatment
The DHE nasal spray delivered pain relief at 2 hours for 66% of patients; 93% of those remained pain-free at 24 hours and 86% at 2 days post-dose.
Young Adults at Highest Risk of Overweight, Obesity over 10 Years
The risk of transition from overweight to obesity and to more severe obesity is highest among those aged 18- to 24-years-old, according to analysis of data from more than 2 million EHRs.
Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with incoming AAFP president Sterling Ransone, MD.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 13, 2021
Fixed-dose Albuterol/Budesonide Superior to Components for Asthma in Dual Phase 3 Trials
The albuterol/budesonide combination significantly reduced the risk of severe exacerbations and improved lung function in mild-to-moderate asthma.